209-260-1

应用筛选条件

关键词:'209-260-1'

显示 1-2 共 2 条结果关于 "209-260-1" 范围论文

Adherence to Anti-Tumor Necrosis Factor Therapy Administered Subcutaneously and Associated Factors in Patients With Rheumatoid Arthritis.

Fausto Salaffi et al.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 21(8), 419-425 (2015-11-21)

Adherence to biologic therapy is relatively poorly studied in rheumatoid arthritis (RA) because many of the studies have investigated the drug persistence, which represents only a surrogate of adherence. The aims of this study were to determine the extent of

Mapping MKP-3/FOXO1 interaction and evaluating the effect on gluconeogenesis.

Ping Jiao et al.

PloS one, 7(7), e41168-e41168 (2012-08-01)

MAP kinase phosphatase 3 (MKP-3) is known to attenuate the ERK signaling pathway. It has been recently demonstrated that MKP-3 is also a player in promoting hepatic glucose output in obese state by interacting and activating FOXO1. Reduction of hepatic

1/1